about
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment.Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4.Protein-energy wasting and mortality in chronic kidney disease.Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic MacrophagesInsulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis.Effect of kidney failure and hemodialysis on protein and amino acid metabolism.Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities.Lysine triggers apoptosis through a NADPH oxidase-dependent mechanism in human renal tubular cells.Interorgan handling of fibroblast growth factor-23 in humans.Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients.Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms.Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney diseaseStudying Muscle Protein Turnover in CKDEffects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings.Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy.The contribution of muscle, kidney and splanchnic tissues to leucine transamination in humans.Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease.Evaluation of metabolic acidosis in patients with a kidney graft: comparison of the bicarbonate-based and strong ion-based methodsMetabolic syndrome is associated with left ventricular dilatation in primary hypertension[Untold stories of kidney metabolism]Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria
P50
Q30358722-384D528C-DC1C-4E47-A18C-5990FA3478FDQ34713167-8A71142F-1936-457D-9D97-618DF83B1BB5Q35024794-2F177471-0D57-4806-989B-923C79FB3FCFQ35939396-C356A59E-20F5-40E4-AF51-977C21D47357Q36369287-F51715BA-79CE-40C3-AD1D-8E6A71DD4EAFQ37959663-643F23AC-B3E5-47D1-9939-B748448BEE30Q38811545-A609956A-6387-45A7-8896-D89E525BA575Q39382915-5968084A-36C4-46E1-9492-96726963EDE7Q39456034-8DAFABC9-22F6-48C6-A0CC-91C846618A96Q39718045-291778F9-FEC5-4FC4-A62A-2B4B9E8BFE18Q41174781-BDDC4909-EE83-45EF-9A7C-41F0178DACFAQ42144013-32BA3C48-D72D-4CE5-A52C-A3147B14DDDBQ42430337-3C7A3B5F-D033-4619-B8FE-67E7D15FF9EAQ43212691-0CF53290-8E55-48CC-A1A9-D0646221F73AQ47769540-1E33D159-A54B-495A-89EB-C6A835B240F3Q50154112-B3B7F09C-56CE-4CC3-BCC3-443C73E4E5CAQ54392913-D1A88822-4AFE-466B-B52A-14ACE5E5D02CQ84211582-E20D35D7-8794-45AA-8D24-7E84972E7F93Q85459129-EA40DD1F-0D20-4DBB-8904-80CE8E138D32Q85788289-EAA3FC0A-252E-4249-AD0A-3212CB0D2E21Q87791764-03A7C1B3-7345-403D-8811-D98DDFC4AF01
P50
description
researcher ORCID ID = 0000-0002-2790-5876
@en
name
Daniela Verzola
@ast
Daniela Verzola
@en
Daniela Verzola
@es
Daniela Verzola
@nl
type
label
Daniela Verzola
@ast
Daniela Verzola
@en
Daniela Verzola
@es
Daniela Verzola
@nl
prefLabel
Daniela Verzola
@ast
Daniela Verzola
@en
Daniela Verzola
@es
Daniela Verzola
@nl
P21
P31
P496
0000-0002-2790-5876